Daniel Billen
Président chez AURINIA PHARMACEUTICALS INC.
Fortune : 162 624 $ au 30/04/2024
Postes actifs de Daniel Billen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Independent Dir/Board Member | 29/04/2019 | - |
| Président | 18/08/2023 | - | |
| Directeur/Membre du Conseil | 29/04/2019 | 18/08/2023 |
Historique de carrière de Daniel Billen
Anciens postes connus de Daniel Billen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2018 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01/01/1991 | 01/01/2011 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Sales & Marketing | 01/01/1979 | 01/01/1991 |
Formation de Daniel Billen
| Université Catholique de Louvain | Doctorate Degree |
Statistiques
Internationale
| Canada | 4 |
| Belgique | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
- Bourse
- Insiders
- Daniel Billen
- Expérience
